Jeffrey Simmons, CEO of Elanco (ELAN), discusses their latest quarter as the stock hits a 52-week low after earnings. He also talks about their new partnership with Medgene for a bird flu vaccine for cattle, which is in the final stages of USDA approval. He adds that they sold their aqua business to pay down debt, and says the “quality of growth” of Elanco should be an investor focus.
======== Schwab Network ========
Empowering every investor and trader, every market day.
Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe
Download the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185
Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7
Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watch
Watch on Vizio - https://www.vizio.com/en/watchfreeplus-explore
Watch on DistroTV - https://www.distro.tv/live/schwab-network/
Follow us on X – https://twitter.com/schwabnetwork
Follow us on Facebook – https://www.facebook.com/schwabnetwork
Follow us on LinkedIn - https://www.linkedin.com/company/schwab-network/
About Schwab Network - https://schwabnetwork.com/about
Fler avsnitt av Schwab Network
Visa alla avsnitt av Schwab NetworkSchwab Network med Schwab Network finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
